These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37881685)

  • 1. Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis [Retraction].
    Onco Targets Ther; 2023; 16():839-840. PubMed ID: 37881685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA LSINCT5 Regulates miR-20a-5p/XIAP to Inhibit the Growth and Metastasis of Osteosarcoma Cells [Retraction].
    Onco Targets Ther; 2020; 13():12197. PubMed ID: 33273824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis.
    Cao MD; Song YC; Yang ZM; Wang DW; Lin YM; Lu HD
    Onco Targets Ther; 2020; 13():8095-8107. PubMed ID: 32884293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-141-3p is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma [Retraction].
    Onco Targets Ther; 2023; 16():497-498. PubMed ID: 37408993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction].
    Onco Targets Ther; 2023; 16():275-276. PubMed ID: 37078010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200b Acts as a Tumor Suppressor in Osteosarcoma via Targeting ZEB1 [Retraction].
    Onco Targets Ther; 2021; 14():4637-4638. PubMed ID: 34511931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4937-4938. PubMed ID: 34611413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of FTX Promotes Osteosarcoma Tumorigenesis by Increasing SOX4 Expression via miR-214-5p [Retraction].
    Onco Targets Ther; 2023; 16():689-690. PubMed ID: 37583707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HS3ST2 and Its Related Molecules as Potential Biomarkers for Predicting Lymph Node Metastasis in Patients with Colorectal Cancer [Retraction].
    Onco Targets Ther; 2022; 15():1041-1042. PubMed ID: 36176728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-618 Directly Targets Metadherin mRNA to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output [Retraction].
    Onco Targets Ther; 2021; 14():4963-4964. PubMed ID: 34629879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression [Retraction].
    Onco Targets Ther; 2021; 14():4743-4744. PubMed ID: 34526780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA CCDC144NL-AS1 Promotes the Oncogenicity of Osteosarcoma by Acting as a Molecular Sponge for microRNA-490-3p and Thereby Increasing HMGA2 Expression [Retraction].
    Onco Targets Ther; 2023; 16():577-578. PubMed ID: 37465587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Influences of RNF6 on Prognosis and Metastasis of Colorectal Cancer: A Clinical Analysis [Retraction].
    Onco Targets Ther; 2020; 13():12199. PubMed ID: 33273825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-139-3p Inhibits the Growth and Metastasis of Ovarian Cancer by Inhibiting ELAVL1 [Retraction].
    Onco Targets Ther; 2022; 15():839-840. PubMed ID: 35942189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of Long Non-Coding RNA Colon Cancer-Associated Transcript 2 Inhibits the Growth and Metastasis of Gastric Cancer Through Blocking mTOR Signaling [Retraction].
    Onco Targets Ther; 2022; 15():1507-1508. PubMed ID: 36530859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-488 Inhibits Cell Growth and Metastasis in Renal Cell Carcinoma by Targeting HMGN5 [Retraction].
    Onco Targets Ther; 2021; 14():3351. PubMed ID: 34045871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KDM5C Expedites Lung Cancer Growth and Metastasis Through Epigenetic Regulation of MicroRNA-133a [Retraction].
    Onco Targets Ther; 2023; 16():315-316. PubMed ID: 37216144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of GIT1 by miR-149* in Breast Cancer Suppresses Cell Proliferation and Metastasis in vitro and Tumor Growth in vivo [Retraction].
    Onco Targets Ther; 2022; 15():1317-1318. PubMed ID: 36338438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYO5A Inhibition by miR-145 Acts as a Predictive Marker of Occult Neck Lymph Node Metastasis in Human Laryngeal Squamous Cell Carcinoma [Retraction].
    Onco Targets Ther; 2023; 16():729-730. PubMed ID: 37694106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs [Retraction].
    Onco Targets Ther; 2023; 16():745-746. PubMed ID: 37719641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.